Literature DB >> 16448463

The role of p28GANK in rat oval cells activation and proliferation.

Yun-Feng Shan1, Wei-Ping Zhou, Xiao-Yong Fu, He-Xing Yan, Wen Yang, Shu-Qin Liu, Hui-Fang Cao, Bin Kang, Meng-Chao Wu, Hong-Yang Wang.   

Abstract

BACKGROUND: Human gankyrin gene product (p28GANK) is a novel oncogenic protein ubiquitously overexpressed in hepatocellular carcinoma and also plays a role in cell cycle progression in normal hepatocytes and liver regeneration. However, little is known about the physiological role of p28GANK in the liver oval cell activation and proliferation. We investigated the possible involvement of p28GANK in oval cell-mediated liver regeneration and cell cycle progression.
METHODS: We examined the different p28GANK expression in 2-acetylaminofuorene/partial heptectomy (2-AAF/PH) rats, as a model of oval cell activation, and PH rats by Western blot and immunohistochemistry. Oval cells isolated from 2-AAF/PH rat model were cultured in our study. p28GANK expression was examined in the oval cells after mitogenic stimulation.
RESULTS: In 2-AAF/PH rats, p28GANK was expressed in the activated oval cells and located in the nucleus. p28GANK protein expression was increased in 2-AFF/PH rats after hepatectomy lasting for 96 h when retinoblastoma maintained hyperphosphorylation status at Ser-795. The isolated oval cells express AFP, OV6, CK19, CD34, CD45, c-kit and albumin. After epidermal growth factor stimulation, p28GANK protein was up-regulated in oval cells from 24 to 72 h, which coincided with increased expression of CyclinD1, CDK4 and decreased of Rb protein.
CONCLUSIONS: p28GANK expression was increased in oval cell-mediated liver regeneration and oval cells after mitogenic stimulation. Thus, p28GANK may play a role in oval cell-mediated liver regeneration and liver oval cell cycle progression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16448463     DOI: 10.1111/j.1478-3231.2005.01203.x

Source DB:  PubMed          Journal:  Liver Int        ISSN: 1478-3223            Impact factor:   5.828


  6 in total

1.  Reference gene selection for real-time RT-PCR in eight kinds of rat regenerating hepatic cells.

Authors:  Gai-Ping Wang; Cun-Shuan Xu
Journal:  Mol Biotechnol       Date:  2010-09       Impact factor: 2.695

2.  Transcriptional profiling of bipotential embryonic liver cells to identify liver progenitor cell surface markers.

Authors:  Scott A Ochsner; Hélène Strick-Marchand; Qiong Qiu; Susan Venable; Adam Dean; Margaret Wilde; Mary C Weiss; Gretchen J Darlington
Journal:  Stem Cells       Date:  2007-07-19       Impact factor: 6.277

Review 3.  Gankyrin as a potential target for tumor therapy: evidence and perspectives.

Authors:  Haixai Li; Junyan Zhang; Cheng Zhen; Baojun Yang; Limin Feng
Journal:  Am J Transl Res       Date:  2018-07-15       Impact factor: 4.060

Review 4.  Intracellular signaling and hepatocellular carcinoma.

Authors:  Polina Iakova; Lubov Timchenko; Nikolai A Timchenko
Journal:  Semin Cancer Biol       Date:  2010-09-17       Impact factor: 15.707

Review 5.  Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.

Authors:  Patrick Arbuthnot; Liam-Jed Thompson
Journal:  World J Gastroenterol       Date:  2008-03-21       Impact factor: 5.742

Review 6.  Structural Insights into Ankyrin Repeat-Containing Proteins and Their Influence in Ubiquitylation.

Authors:  Emma I Kane; Donald E Spratt
Journal:  Int J Mol Sci       Date:  2021-01-09       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.